186 related articles for article (PubMed ID: 25832411)
1. PLD3 in non-familial Alzheimer's disease.
Heilmann S; Drichel D; Clarimon J; Fernández V; Lacour A; Wagner H; Thelen M; Hernández I; Fortea J; Alegret M; Blesa R; Mauleón A; Roca MR; Kornhuber J; Peters O; Heun R; Frölich L; Hüll M; Heneka MT; Rüther E; Riedel-Heller S; Scherer M; Wiltfang J; Jessen F; Becker T; Tárraga L; Boada M; Maier W; Lleó A; Ruiz A; Nöthen MM; Ramirez A
Nature; 2015 Apr; 520(7545):E3-5. PubMed ID: 25832411
[No Abstract] [Full Text] [Related]
2. PLD3 gene variants and Alzheimer's disease.
Hooli BV; Lill CM; Mullin K; Qiao D; Lange C; Bertram L; Tanzi RE
Nature; 2015 Apr; 520(7545):E7-8. PubMed ID: 25832413
[No Abstract] [Full Text] [Related]
3. PLD3 and sporadic Alzheimer's disease risk.
Lambert JC; Grenier-Boley B; Bellenguez C; Pasquier F; Campion D; Dartigues JF; Berr C; Tzourio C; Amouyel P
Nature; 2015 Apr; 520(7545):E1. PubMed ID: 25832408
[No Abstract] [Full Text] [Related]
4. PLD3 variants in population studies.
van der Lee SJ; Holstege H; Wong TH; Jakobsdottir J; Bis JC; Chouraki V; van Rooij JG; Grove ML; Smith AV; Amin N; Choi SH; Beiser AS; Garcia ME; van IJcken WF; Pijnenburg YA; Louwersheimer E; Brouwer RW; van den Hout MC; Oole E; Eirkisdottir G; Levy D; Rotter JI; Emilsson V; O'Donnell CJ; Aspelund T; Uitterlinden AG; Launer LJ; Hofman A; Boerwinkle E; Psaty BM; DeStefano AL; Scheltens P; Seshadri S; van Swieten JC; Gudnason V; van der Flier WM; Ikram MA; van Duijn CM
Nature; 2015 Apr; 520(7545):E2-3. PubMed ID: 25832410
[No Abstract] [Full Text] [Related]
5. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.
Cruchaga C; Karch CM; Jin SC; Benitez BA; Cai Y; Guerreiro R; Harari O; Norton J; Budde J; Bertelsen S; Jeng AT; Cooper B; Skorupa T; Carrell D; Levitch D; Hsu S; Choi J; Ryten M; Sassi C; Bras J; Gibbs RJ; Hernandez DG; Lupton MK; Powell J; Forabosco P; Ridge PG; Corcoran CD; Tschanz JT; Norton MC; Munger RG; Schmutz C; Leary M; Demirci FY; Bamne MN; Wang X; Lopez OL; Ganguli M; Medway C; Turton J; Lord J; Braae A; Barber I; Brown K; ; Pastor P; Lorenzo-Betancor O; Brkanac Z; Scott E; Topol E; Morgan K; Rogaeva E; Singleton A; Hardy J; Kamboh MI; George-Hyslop PS; Cairns N; Morris JC; Kauwe JSK; Goate AM
Nature; 2014 Jan; 505(7484):550-554. PubMed ID: 24336208
[TBL] [Abstract][Full Text] [Related]
6. Rare Variants in PLD3 Increase Risk for Alzheimer's Disease in Han Chinese.
Tan MS; Zhu JX; Cao XP; Yu JT; Tan L
J Alzheimers Dis; 2018; 64(1):55-59. PubMed ID: 29865074
[TBL] [Abstract][Full Text] [Related]
7. Cruchaga & Goate reply.
Cruchaga C; Goate AM
Nature; 2015 Apr; 520(7545):E5-6. PubMed ID: 25832412
[No Abstract] [Full Text] [Related]
8. Cruchaga & Goate reply.
Cruchaga C; Goate AM
Nature; 2015 Apr; 520(7545):E10. PubMed ID: 25832409
[No Abstract] [Full Text] [Related]
9. The effect of rare variants in TREM2 and PLD3 on longitudinal cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
Engelman CD; Darst BF; Bilgel M; Vasiljevic E; Koscik RL; Jedynak BM; Johnson SC
Neurobiol Aging; 2018 Jun; 66():177.e1-177.e5. PubMed ID: 29395285
[TBL] [Abstract][Full Text] [Related]
10. PLD3 is a neuronal lysosomal phospholipase D associated with β-amyloid plaques and cognitive function in Alzheimer's disease.
Nackenoff AG; Hohman TJ; Neuner SM; Akers CS; Weitzel NC; Shostak A; Ferguson SM; Mobley B; Bennett DA; Schneider JA; Jefferson AL; Kaczorowski CC; Schrag MS
PLoS Genet; 2021 Apr; 17(4):e1009406. PubMed ID: 33830999
[TBL] [Abstract][Full Text] [Related]
11. PLD3 in Alzheimer's Disease: a Modest Effect as Revealed by Updated Association and Expression Analyses.
Zhang DF; Fan Y; Wang D; Bi R; Zhang C; Fang Y; Yao YG
Mol Neurobiol; 2016 Aug; 53(6):4034-4045. PubMed ID: 26189833
[TBL] [Abstract][Full Text] [Related]
12. Rare Variants in PLD3 Do Not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium Cohort.
Cacace R; Van den Bossche T; Engelborghs S; Geerts N; Laureys A; Dillen L; Graff C; Thonberg H; Chiang HH; Pastor P; Ortega-Cubero S; Pastor MA; Diehl-Schmid J; Alexopoulos P; Benussi L; Ghidoni R; Binetti G; Nacmias B; Sorbi S; Sanchez-Valle R; Lladó A; Gelpi E; Almeida MR; Santana I; Tsolaki M; Koutroumani M; Clarimon J; Lleó A; Fortea J; de Mendonça A; Martins M; Borroni B; Padovani A; Matej R; Rohan Z; Vandenbulcke M; Vandenberghe R; De Deyn PP; Cras P; van der Zee J; Sleegers K; Van Broeckhoven C;
Hum Mutat; 2015 Dec; 36(12):1226-35. PubMed ID: 26411346
[TBL] [Abstract][Full Text] [Related]
13. V232M substitution restricts a distinct O-glycosylation of PLD3 and its neuroprotective function.
Demirev AV; Song HL; Cho MH; Cho K; Peak JJ; Yoo HJ; Kim DH; Yoon SY
Neurobiol Dis; 2019 Sep; 129():182-194. PubMed ID: 31121321
[TBL] [Abstract][Full Text] [Related]
14. Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond.
Cuyvers E; Sleegers K
Lancet Neurol; 2016 Jul; 15(8):857-868. PubMed ID: 27302364
[TBL] [Abstract][Full Text] [Related]
15. No association of spastic paraparesis genes in PSEN1 Alzheimer's disease with spastic paraparesis.
Karlstrom H; Kwok JB; Gregory GC; Hallupp M; Brooks WS; Schofield PR
Neuroreport; 2007 Aug; 18(12):1267-9. PubMed ID: 17632280
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's (AD).
J Pract Nurs; 2009; 59(2):5-7. PubMed ID: 19718998
[No Abstract] [Full Text] [Related]
17. Cognitive phenotypes in Alzheimer's disease and genetic variants in ACE and IDE.
Vardy ER; Brown K; Stopford CL; Thompson JC; Richardson AM; Neary D; Kalsheker N; Morgan K; Mann DM; Snowden JS
Neurobiol Aging; 2012 Jul; 33(7):1486.e1-2. PubMed ID: 21232820
[TBL] [Abstract][Full Text] [Related]
18. Age-dependent association of KIBRA genetic variation and Alzheimer's disease risk.
Rodríguez-Rodríguez E; Infante J; Llorca J; Mateo I; Sánchez-Quintana C; García-Gorostiaga I; Sánchez-Juan P; Berciano J; Combarros O
Neurobiol Aging; 2009 Feb; 30(2):322-4. PubMed ID: 17707552
[TBL] [Abstract][Full Text] [Related]
19. Heritability of plasma amyloid beta in typical late-onset Alzheimer's disease pedigrees.
Ertekin-Taner N; Graff-Radford N; Younkin LH; Eckman C; Adamson J; Schaid DJ; Blangero J; Hutton M; Younkin SG
Genet Epidemiol; 2001 Jul; 21(1):19-30. PubMed ID: 11443731
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in the tau kinases pathway may modify the risk and age at onset of Alzheimer's disease.
Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Calero M; Dobato JL; Frank-García A; Valdivieso F; Berciano J; Bullido MJ; Combarros O
J Alzheimers Dis; 2011; 27(2):291-7. PubMed ID: 21811019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
